secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0001193125-23-147662
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

FTC obtains stipulated TRO blocking Amgen's Horizon acquisition until Sept 15 or court ruling
--------------------------------------------------------------------------------

- FTC filed complaint May 16, 2023 in N.D. Illinois seeking to enjoin $27.8B acquisition of Horizon Therapeutics.
- Stipulated TRO granted May 17, 2023: Amgen and Horizon cannot close deal until Sept 15, 2023 or 2nd business day after court rules on FTC's preliminary injunction request.
- Parties agreed to the stipulated TRO to allow court to consider the FTC's request.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000119312523147662/0001193125-23-147662-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000119312523147662/d499865d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-147662

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer